Xenon Pharmaceuticals Inc. XENE

CA Biotechnology

$40.49 ▲ +0.10% (+$0.04)

Open $40.28

Prev Close $40.45

Day Range $40.09 – $41.15

52W Range $33.38 – $72.66

Market Cap $3.62B

Beta 0.03

EPS (TTM) $-4.74

📋 Company Profile

Industry	Biotechnology
Country	CA
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2014-10-17
Shares Out.	96,840,000
Website	xenon-pharma.com/ ↗
Phone	16044843300
Employees	370
Revenue	$0
Gross Profit	$0
Net Income	-$110.7M
Free Cash Flow	-$338.5M
Total Assets	$1.30B
Total Liabilities	$53.4M
Equity	$1.24B

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Xenon Pharmaceuticals Inc. is a publicly traded company under the ticker symbol XENE on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.